|
Video: What is a Stock Split?
|
|
Olink Holdings is engaged in the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across major biopharmaceutical companies and clinical and academic institutions. Co.'s products and services play a role in decoding the biology of almost all disease areas and are used most frequently in immunology, oncology, neurology, cardiovascular and metabolic diseases. Co.'s offering is based on its proprietary and patented Proximity Extension Assay (PEA) technology, which enables researchers to use one platform from discovery to clinical trials. PEA comprises three product lines: Explore, Target, and Focus. According to our Olink Holdings AB stock split history records, Olink Holdings AB has had 0 splits. | |
|
Olink Holdings AB (OLK) has 0 splits in our Olink Holdings AB stock split history database.
Looking at the Olink Holdings AB stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Olink Holdings AB shares, starting with a $10,000 purchase of OLK, presented on a split-history-adjusted basis factoring in the complete Olink Holdings AB stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/29/2021 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$31.90 |
|
End price/share: |
$23.07 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-27.68% |
|
Average Annual Total Return: |
-10.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,231.32 |
|
Years: |
3.08 |
|
|
|
|
|